Tortoise Investment Management, LLC - GLOBAL BLOOD THERAPEUTICS IN ownership

GLOBAL BLOOD THERAPEUTICS IN's ticker is GBT and the CUSIP is 37890U108. A total of 198 filers reported holding GLOBAL BLOOD THERAPEUTICS IN in Q2 2021. The put-call ratio across all filers is 0.17 and the average weighting 0.1%.

Quarter-by-quarter ownership
Tortoise Investment Management, LLC ownership history of GLOBAL BLOOD THERAPEUTICS IN
ValueSharesWeighting
Q2 2022$40,000
-9.1%
1,2670.0%0.01%0.0%
Q1 2022$44,000
+18.9%
1,2670.0%0.01%
+14.3%
Q4 2021$37,000
+15.6%
1,2670.0%0.01%
+16.7%
Q3 2021$32,000
-27.3%
1,2670.0%0.01%
-33.3%
Q2 2021$44,000
-15.4%
1,2670.0%0.01%
-18.2%
Q1 2021$52,000
-5.5%
1,2670.0%0.01%
-15.4%
Q4 2020$55,000
-21.4%
1,2670.0%0.01%
-23.5%
Q3 2020$70,000
-12.5%
1,2670.0%0.02%
-19.0%
Q2 2020$80,000
+23.1%
1,2670.0%0.02%
+10.5%
Q1 2020$65,000
-35.6%
1,2670.0%0.02%
-20.8%
Q4 2019$101,000
+65.6%
1,2670.0%0.02%
+50.0%
Q3 2019$61,000
-9.0%
1,2670.0%0.02%
-5.9%
Q2 2019$67,0000.0%1,2670.0%0.02%
-5.6%
Q1 2019$67,000
+28.8%
1,2670.0%0.02%
+28.6%
Q4 2018$52,000
+8.3%
1,2670.0%0.01%
+7.7%
Q3 2018$48,000
-15.8%
1,2670.0%0.01%
-18.8%
Q2 2018$57,000
-38.0%
1,267
-33.6%
0.02%
-36.0%
Q1 2018$92,000
+22.7%
1,9070.0%0.02%
+13.6%
Q4 2017$75,000
+27.1%
1,9070.0%0.02%
+22.2%
Q3 2017$59,000
+13.5%
1,9070.0%0.02%
+5.9%
Q2 2017$52,000
-25.7%
1,9070.0%0.02%
-26.1%
Q1 2017$70,000
+150.0%
1,9070.0%0.02%
+130.0%
Q4 2016$28,000
-36.4%
1,9070.0%0.01%
-33.3%
Q3 2016$44,000
+37.5%
1,9070.0%0.02%
+36.4%
Q2 2016$32,000
-28.9%
1,907
-33.3%
0.01%
-31.2%
Q1 2016$45,0002,8570.02%
Other shareholders
GLOBAL BLOOD THERAPEUTICS IN shareholders Q2 2021
NameSharesValueWeighting ↓
Alerce Investment Management, L.P. 356,270$24,262,00023.36%
Twin Securities, Inc. 376,669$25,651,00011.94%
Paradigm Biocapital Advisors LP 1,175,879$80,077,00010.68%
Chicago Capital Management, LLC 246,246$16,769,0009.12%
HARVEST MANAGEMENT LLC 141,500$9,636,0007.78%
Fernwood Investment Management, LLC 174,724$11,899,0005.02%
ArchPoint Investors 168,725$11,490,0004.69%
HAVENS ADVISORS LLC 46,000$3,133,0004.69%
Perceptive Advisors 2,322,247$158,145,0004.59%
Crabel Capital Management, LLC 112,680$7,674,0004.48%
View complete list of GLOBAL BLOOD THERAPEUTICS IN shareholders